Low childhood high density lipoprotein cholesterol levels and subsequent risk for chronic inflammatory bowel disease.

[1]  V. Annese,et al.  The natural history of Crohn’s disease in children: a review of population-based studies , 2017, European journal of gastroenterology & hepatology.

[2]  L. Virta,et al.  Inflammatory Bowel Disease Incidence is on the Continuous Rise Among All Paediatric Patients Except for the Very Young: A Nationwide Registry-based Study on 28-Year Follow-up , 2017, Journal of Crohn's & colitis.

[3]  A. Tuttolomondo,et al.  Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease. , 2017, European journal of internal medicine.

[4]  K. Feingold,et al.  Effect of inflammation on HDL structure and function , 2016, Current opinion in lipidology.

[5]  Allison R. Schulman,et al.  Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database , 2016, Inflammatory bowel diseases.

[6]  A. Auvinen,et al.  Incidence of Pediatric Inflammatory Bowel Disease in Finland: An Environmental Study , 2016, Journal of pediatric gastroenterology and nutrition.

[7]  S. Mehandru,et al.  Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease , 2016, The American Journal of Gastroenterology.

[8]  E. Pac-Kożuchowska,et al.  Inflammatory and Lipid-Associated Markers of Cardiovascular Diseases in Children with First Exacerbation of Inflammatory Bowel Disease , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[9]  A. Ananthakrishnan,et al.  Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis , 2016, Inflammatory bowel diseases.

[10]  Tariq Ahmad,et al.  Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study , 2016, The Lancet.

[11]  C. Fiocchi,et al.  Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.

[12]  G. Kaplan,et al.  The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.

[13]  C. Romano,et al.  Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis , 2015, Front. Immunol..

[14]  T. Lehtimäki,et al.  Infection-Related Hospitalization in Childhood and Adult Metabolic Outcomes , 2015, Pediatrics.

[15]  C. Klein,et al.  Very Early-onset Inflammatory Bowel Disease: Gaining Insight Through Focused Discovery , 2015, Gastroenterology & hepatology.

[16]  Fei Li,et al.  The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis. , 2015, Clinical and experimental rheumatology.

[17]  I. Kullo,et al.  Epidemiology, risk factors and management of cardiovascular diseases in IBD , 2015, Nature Reviews Gastroenterology &Hepatology.

[18]  R. Erichsen,et al.  Prognosis After First-Time Myocardial Infarction in Patients With Inflammatory Bowel Disease According to Disease Activity: Nationwide Cohort Study , 2014, Circulation. Cardiovascular quality and outcomes.

[19]  L. Virta,et al.  Mortality and causes of death in patients with inflammatory bowel disease: a nationwide register study in Finland. , 2014, Journal of Crohn's & colitis.

[20]  G. Norata,et al.  HDL in innate and adaptive immunity. , 2014, Cardiovascular research.

[21]  A. Fatemi,et al.  Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial , 2014, Clinical Rheumatology.

[22]  G. Veres,et al.  Incidence, Paris Classification, and Follow-up in a Nationwide Incident Cohort of Pediatric Patients With Inflammatory Bowel Disease , 2013, Journal of pediatric gastroenterology and nutrition.

[23]  Tanya M. Teslovich,et al.  Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.

[24]  V. Salomaa,et al.  High and increasing prevalence of inflammatory bowel disease in Finland with a clear North-South difference. , 2013, Journal of Crohn's & colitis.

[25]  J. Wohlfahrt,et al.  Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study , 2012, Gut.

[26]  R. Sund.  Quality of the Finnish Hospital Discharge Register: A systematic review , 2012, Scandinavian journal of public health.

[27]  Seth D. Crockett,et al.  Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study* , 2012, Inflammatory bowel diseases.

[28]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[29]  C. Brensinger,et al.  No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  A. Auvinen,et al.  Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study , 2011, Inflammatory bowel diseases.

[31]  Philippe Seksik,et al.  Epidemiology and natural history of inflammatory bowel diseases. , 2011, Gastroenterology.

[32]  M. Färkkilä,et al.  Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. , 2011, Journal of Crohn's & colitis.

[33]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[34]  D. Peng,et al.  HDL and immunomodulation: an emerging role of HDL against atherosclerosis , 2010, Immunology and cell biology.

[35]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[36]  M. Färkkilä,et al.  Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey , 2008, Scandinavian journal of gastroenterology.

[37]  C. Bernstein,et al.  The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  阎明,et al.  Epidemiology and Natural History of Inflammatory Bowel Disease , 2001 .

[39]  J. Viikari,et al.  Atherosclerosis precursors in Finnish children and adolescents. X. Leisure‐time physical activity , 1985, Acta paediatrica Scandinavica. Supplement.